Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 7;74(5):773-6.
doi: 10.1016/j.neuron.2012.05.004.

Pharmacogenomics and personalized medicine in neuropsychiatry

Francis J McMahon  1 , Thomas R Insel
Affiliations

Pharmacogenomics and personalized medicine in neuropsychiatry

Francis J McMahon et al. Neuron. .

Abstract

Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The nested relationship between personalized medicine, genomic medicine, and pharmacogenetics and genomics.
Figure 2
Figure 2
Approaches to the pharmacogenomics of psychotropic medications. Individual variation reflects both genetic and non-genetic factors that converge on the absorption, distribution, central target, metabolism, and toxicity of medications.
See this image and copyright information in PMC

References

    1. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I, Reid JG, Fink JK, Morgan MB, Gingras MC, et al. Whole-genome sequencing for optimized patient management. Sci Transl Med. 2011;3 87re3. - PMC - PubMed
    1. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B, Papiol S, Seaman S, Lucae S, Kohli MA, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36:1319–1325. - PubMed
    1. Black JL, 3rd, O'Kane DJ, Mrazek DA. The impact of CYP allelic variation on antidepressant metabolism: A review. Expert Opin Drug Metab Toxicol. 2007;3:21–31. - PubMed
    1. Carlquist JF, Anderson JL. Using pharmacogenetics in real time to guide warfarin initiation: A clinician update. Circulation. 2011;124:2554–2559. - PubMed
    1. Chowdhury NI, Remington G, Kennedy JL. Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep. 2011;13:156–165. - PubMed

Publication types

Substances